These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22014157)

  • 1. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
    Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
    Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
    Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B
    Malar J; 2013 Mar; 12():107. PubMed ID: 23510258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
    Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.
    Fall B; Camara C; Fall M; Nakoulima A; Dionne P; Diatta B; Diemé Y; Wade B; Pradines B
    Malar J; 2015 Feb; 14():60. PubMed ID: 25849097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.
    Pascual A; Parola P; Benoit-Vical F; Simon F; Malvy D; Picot S; Delaunay P; Basset D; Maubon D; Faugère B; Ménard G; Bourgeois N; Oeuvray C; Didillon E; Rogier C; Pradines B
    Malar J; 2012 Feb; 11():45. PubMed ID: 22333675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
    Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B
    Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
    Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
    Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
    Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
    Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B
    Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal.
    Pascual A; Fall B; Wurtz N; Fall M; Camara C; Nakoulima A; Baret E; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Bogreau H; Briolant S; Rogier C; Wade B; Pradines B
    Malar J; 2013 Jun; 12():189. PubMed ID: 23758769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015.
    Fall B; Madamet M; Diawara S; Briolant S; Wade KA; Lo G; Nakoulima A; Fall M; Bercion R; Kounta MB; Amalvict R; Benoit N; Gueye MW; Diatta B; Wade B; Pradines B
    Int J Antimicrob Agents; 2017 Aug; 50(2):155-158. PubMed ID: 28689867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
    Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K
    Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.
    Mbaye A; Gaye A; Dieye B; Ndiaye YD; Bei AK; Affara M; Deme AB; Yade MS; Diongue K; Ndiaye IM; Ndiaye T; Sy M; Sy N; Koita O; Krogstad DJ; Volkman S; Nwakanma D; Ndiaye D
    Malar J; 2017 Jun; 16(1):250. PubMed ID: 28615016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
    Nsobya SL; Kiggundu M; Nanyunja S; Joloba M; Greenhouse B; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1200-6. PubMed ID: 20065051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
    Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
    Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
    Tinto H; Bonkian LN; Nana LA; Yerbanga I; Lingani M; Kazienga A; Valéa I; Sorgho H; Kpoda H; Guiguemdé TR; Ouédraogo JB; Mens PF; Schallig H; D'Alessandro U
    Malar J; 2014 May; 13():207. PubMed ID: 24885950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.